Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Kolling Institute Tumour Bank
Events, News and Seminars
New funding supports innovative approach to diagnose heart failure
Posted on: 14 December, 2020
Kolling researcher and Royal North Shore Hospital cardiologist Dr Rebecca Kozor will lead a world-fi..... Read more
Category: Funding support
Every week counts in the lead up to birth
Posted on: 14 December, 2020
The Kolling’s Women and Babies Research team is calling for a reduction in the number of early birth..... Read more
Category: Research Excellence
Cancer expertise recognised
Posted on: 10 December, 2020
The Kolling’s Dr Amanda Hudson will lead an exciting pilot study after being awarded an innovation g..... Read more
Category: Funding support